Previvors Recharge: A Resilience Program for Cancer Previvors
PreCharge
1 other identifier
interventional
138
1 country
1
Brief Summary
It is estimated that 1 in 279 people may be carriers of a Hereditary Cancer Syndromes (HCS), a cancer risk that is associated with germline mutations (inherited genetic mutations passed directly from a parent to a child that create a genetic predisposition to certain types of cancer). Individuals with an HCS who have never been diagnosed with cancer (Previvors) have up to an 80% lifetime risk of developing cancer and are at an increased risk of developing multiple primary cancers during their lifetime, often with onset at an early age. Previvors face multiple forms of adversity, including a multitude of annual cancer screenings and the uncertainty of not only their own health but the health of affected family members. This study will examine the acceptability and preliminary effects of PreCharge, a resilience-boosting solution specifically designed for Previvors and delivered primarily via bi-directional text messaging. PreCharge uses proven approaches to behavior change tailoring to increase resilience by promoting a positive mindset, strong social connections, and a deep sense of meaning and purpose while also proactively addressing scanxiety. Up to 150 Hereditary Cancer Previvors will be recruited for a 30-day pilot test. Participants will complete a baseline assessment, and then be provided with 30 days of access to the PreCharge program. At the end of the 30 days, they will be prompted to complete a follow-up assessment. Outcomes to be examined will include pre-post changes on the Connor Davidson Resilience Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 11, 2024
CompletedFirst Submitted
Initial submission to the registry
April 17, 2024
CompletedFirst Posted
Study publicly available on registry
April 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 27, 2024
CompletedResults Posted
Study results publicly available
May 21, 2025
CompletedMay 21, 2025
May 1, 2025
6 months
April 17, 2024
April 30, 2025
May 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Connor Davidson Resilience Scale (CDRISC)
This 10-item scale assesses five factors related to resilience. Each item is rated on a 5-point scale with higher scores reflecting greater resilience. Scores range from 0-40. There are well-established norms across a variety of populations and the scale has been used as an outcome measure to evaluate a variety of different intervention programs.
Baseline and 1 Month
Secondary Outcomes (1)
Acceptance and Action Questionnaire (AAQII)
Baseline and 1 Month
Other Outcomes (3)
Patient Health Questionnaire-2 (PHQ-2)
Baseline and 1 Month
Generalized Anxiety Disorder-2 (GAD-2)
Baseline and 1 Month
Cancer Behavior Inventory (CBI-B V2.0-12)
Baseline and 1 Month
Study Arms (1)
PreCharge Intervention Pilot
EXPERIMENTALAfter completing the baseline assessment, all pilot participants will have access to the PreCharge pilot program for 30 days. At the end of the 30 day pilot, they will be directed to the follow-up assessment.
Interventions
PreCharge is an intervention for Hereditary Cancer Syndrome Previvors that administers brief assessments and uses multivariate algorithms and tailoring technology to provide timely, individualized, bi-directional text messages to improve resilience and coping. The program uses proven approaches to behavior change tailoring to increase resilience by promoting a positive mindset, strong social connections, and a deep sense of meaning and purpose. It will also proactively provide access to online tools prior to medical appointments to address scanxiety (e.g., management of emotion tips; mindfulness meditation; communication scripts; breathing exercises). At any time, users will be able to text a trigger word to indicate that they need extra support and will receive just-in-time assistance via text message.
Eligibility Criteria
You may qualify if:
- Identified as having Hereditary Cancer Syndrome
- Never having been diagnosed with cancer
- Over 18 years of age
- Living in the United States
- English speaking
- Having a score of 26 or below on the Connor Davidson Resilience Scale (10 Item)
- Access to a mobile phone
- Agree to receive text messages.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pro-Change Behavior Systems
Narragansett, Rhode Island, 02882, United States
Results Point of Contact
- Title
- Kerry E. Evers
- Organization
- Pro-Change Behavior Systems, Inc.
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-President and CEO, Principal Investigator
Study Record Dates
First Submitted
April 17, 2024
First Posted
April 22, 2024
Study Start
April 11, 2024
Primary Completion
September 27, 2024
Study Completion
September 27, 2024
Last Updated
May 21, 2025
Results First Posted
May 21, 2025
Record last verified: 2025-05